Sort
50,496 grants matching “lung cancer”
Smoking cessation in lung cancer screening: integrated digital/clinical approach
$601,796J Taylor Hays · Mayo Clinic Rochester · R01 · FY2017 · CA
Serum Levels of EGFR-Signaling-Network Activators/Inhibitor and Lung Cancer Risk
$601,771Gloria Yf Ho · Albert Einstein College Of Medicine · R01 · FY2011 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis
$601,752Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2021 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis
$601,750Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients
$601,720Matthew B Weinger · Vanderbilt University Medical Center · R18 · FY2020 · HS
Prostate Cancer Studies
$601,704Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer
$601,550Livia Schiavinato Eberlin · Baylor College Of Medicine · R01 · FY2023 · CA
Probing RAS-mediated Signaling with Monobody Inhibitors
$601,496John P O'Bryan · Medical University Of South Carolina · R01 · FY2022 · CA
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
$601,421Mark W Geraci · University Of Colorado Denver · R01 · FY2012 · CA
Genetic Epidemiology of Cancer
$601,408Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2015 · HG
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$601,400Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2019 · CA
Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging
$601,359Farhood Farjah · University Of Washington · R01 · FY2025 · CA
Using patient-derived models to understand drug responses in SCLC
$601,323Nicholas J Dyson · Massachusetts General Hospital · U01 · FY2019 · CA
Case-cohort study of Cancers in Excess in Poultry Workers
$601,314Mohammed F Elfaramawi · Univ Of Arkansas For Med Scis · R01 · FY2019 · OH
S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
$601,271Craig A Henke · University Of Minnesota · R01 · FY2020 · HL
Inflammation and Cancer
$601,256Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Biomarkers of Human Lung Cancer
$601,256Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment
$601,253Yubin Miao · University Of Colorado Denver · R01 · FY2024 · CA
Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral Neuropathy
$601,172Daniel Louis Hertz · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Effect of Tobacco Advocacy at the State Level
$601,171Stanton Arnold Glantz · University Of California, San Francisco · R01 · FY2008 · CA
Multi-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy Controls
$601,168Zachary David Nagel · Harvard School Of Public Health · U01 · FY2022 · ES
Damage-associated molecular patterns in chemotherapy toxicity
$601,091Eric Daniel Eisenmann · Ohio State University · R37 · FY2025 · CA
Basic applications for total-body PET in oncology
$601,074Lorenzo Nardo · University Of California At Davis · R01 · FY2023 · CA
Sex Hormones in Pulmonary Arterial Hypertension
$601,064James E Loyd · Vanderbilt University Medical Center · P01 · FY2018 · HL
Molecular mechanisms underlying lineage plasticity in prostate cancer
$601,022Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2025 · CA